About Alpex Pharma
Alpex Pharma is a company based in Mezzovico-vira (Switzerland) founded in 2000. Alpex Pharma has raised $9.05 million across 1 funding round from investors including BB Biotech Ventures and Signet Healthcare Partners. Alpex Pharma offers products and services including Pharmaceutical Products, Nutraceuticals, and Formulation Development. Alpex Pharma operates in a competitive market with competitors including Kapiva, Jubilant Life Sciences, Recipharm, ChromaDex and Akums, among others.
- Headquarter Mezzovico-vira, Switzerland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Alpex Pharma Sa
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$9.05 M (USD)
in 1 rounds
-
Latest Funding Round
$9.05 M (USD), Series B
Aug 22, 2007
-
Investors
BB Biotech Ventures
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alpex Pharma
Alpex Pharma offers a comprehensive portfolio of products and services, including Pharmaceutical Products, Nutraceuticals, and Formulation Development.
Innovative drugs for therapeutic areas like pain management.
Nutritional products supporting wellness and disease prevention.
Services for developing and scaling pharmaceutical formulations.
Funding Insights of Alpex Pharma
Alpex Pharma has successfully raised a total of $9.05M through 1 strategic funding round. The most recent funding activity was a Series B round of $9.05 million completed in August 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Alpex Pharma
Alpex Pharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include BB Biotech Ventures and Signet Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
PE firm investing in North America and Europe
|
Locked | Locked | Locked |
Investor details for Alpex Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Alpex Pharma
Investment portfolio details for Alpex Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Alpex Pharma
Detailed financials for Alpex Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Alpex Pharma Comparisons
Peer comparison for Alpex Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Alpex Pharma
Alpex Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kapiva, Jubilant Life Sciences, Recipharm, ChromaDex and Akums, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Ayurvedic healthcare and nutritional products are provided by Kapiva.
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
Nutritional ingredients for health and wellness are developed.
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
Detailed competitors of Alpex Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Alpex Pharma
Complete news archive for Alpex Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alpex Pharma
Alpex Pharma was founded in 2000 and raised its 1st funding round 7 years after it was founded.
Alpex Pharma is headquartered in Mezzovico-vira, Switzerland. It is registered at Mezzovico-vira, Ticino, Switzerland.
Shahbaz Ardalan is the current CEO of Alpex Pharma.
Alpex Pharma is a funded company, having raised a total of $9.05M across 1 funding round to date.
Alpex Pharma was founded in 2000 and is based in Mezzovico Vira, Switzerland. Operations focus on the pharmaceutical sector as a contract research organization. Services encompass contract manufacturing, formulation development, nutritional supplements, prescription products, and drug delivery solutions. RD projects are also conducted for orodispersible tablet versions of existing drugs. Leadership is provided by CEO MD Shahbaz Ardalan.
Alpex Pharma's top competitors include Kapiva, Jubilant Life Sciences and Akums.
Alpex Pharma offers Pharmaceutical Products, Nutraceuticals, and Formulation Development.
Alpex Pharma has 2 investors. Key investors include BB Biotech Ventures, and Signet Healthcare Partners.